OpenURL Connection Search

Select item for more details and to access through your institution.

Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.
Published in:
2001
By:
- Kosmas, Christos;
- Tsavaris, Nicolas;
- Vadiaka, Maria;
- Stavroyianni, Niki;
- Koutras, Angelos;
- Malamos, Nikolaos;
- Onyenadum, Adimchi;
- Rokana, Sofia;
- Polyzos, Aristidis;
- Kalofonos, Haralambos P.;
- Kosmas, C;
- Tsavaris, N;
- Vadiaka, M;
- Stavroyianni, N;
- Koutras, A;
- Malamos, N;
- Onyenadum, A;
- Rokana, S;
- Polyzos, A;
- Kalofonos, H P
Publication type:
journal article
A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.
Published in:
2000
By:
- Kosmas, Christos;
- Tsavaris, Nicolas B.;
- Polyzos, Aristidis;
- Kalofonos, Haralambos P.;
- Sepsas, Evangelos;
- Malamos, Nikolaos A.;
- Vadiaka, Maria;
- Dosios, Theodosios;
- Antonopoulos, Minas J.;
- Kosmas, C;
- Tsavaris, N B;
- Polyzos, A;
- Kalofonos, H P;
- Sepsas, E;
- Malamos, N A;
- Vadiaka, M;
- Dosios, T;
- Antonopoulos, M J
Publication type:
journal article
Irinotecan (CPT-11) in Patients with Advanced Colon Carcinoma Relapsing after 5-Fluorouracil-Leucovorin Combination.
Published in:
Chemotherapy (0009-3157), 2002, v. 48, n. 2, p. 94, doi. 10.1159/000057669
By:
- Tsavaris, N.B.;
- Polyzos, A.;
- Gennatas, K.;
- Kosmas, Ch.;
- Vadiaka, M.;
- Dimitrakopoulos, A.;
- Macheras, A.;
- Papastratis, G.;
- Tsipras, H.;
- Margaris, H.;
- Papalambros, E.;
- Giannopoulos, A.;
- Koufos, Ch.
Publication type:
Article
Ondansentron and Dexamethasone Treatment with Different Dosing Schedules (24 versus 32 mg) in Patients with Non-Small-Cell Lung Cancer under Cisplatin-Based Chemotherapy:A Randomized Stud y.
Published in:
Chemotherapy (0009-3157), 2000, v. 46, n. 5, p. 364, doi. 10.1159/000007310
By:
- Tsavaris, N.;
- Kosmas, Ch.;
- Vadiaka, M.;
- Kanelopoulos, P.;
- Kontos, A.;
- Katsorida, M.;
- Agelopoulou, A.;
- Vrizidis, N.;
- Fotia, M.;
- Papoutsis, K.;
- Koufos, Ch.
Publication type:
Article
Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study.
Published in:
2003
By:
- Tsavaris, N.;
- Ziras, N.;
- Kosmas, C.;
- Giannakakis, T.;
- Gouveris, P.;
- Vadiaka, M.;
- Dimitrakopoulos, A.;
- Karadima, D.;
- Rokana, S.;
- Papalambros, E.;
- Papastratis, G.;
- Margaris, H.;
- Tsipras, H.;
- Polyzos, A.
Publication type:
journal article
Efficacy of tropisetron in patients with advanced non-small-cell lung cancer receiving adjuvant chemotherapy with carboplatin and taxanes.
Published in:
European Journal of Cancer Care, 2008, v. 17, n. 2, p. 167, doi. 10.1111/j.1365-2354.2007.00829.x
By:
- TSAVARIS, N.;
- KOSMAS, C.;
- KOPTERIDES, P.;
- VADIAKA, M.;
- KOSMAS, N.;
- SKOPELITIS, H.;
- KARADIMA, D.;
- KOLLIOKOSTA, G.;
- TZIMA, E.;
- LOUKERIS, D.;
- PAGOUNI, E.;
- BATZIOU, E.;
- XYLA, V.;
- KOUFOS, C.
Publication type:
Article
Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes.
Published in:
2002
By:
- Tsavaris, N.;
- Kosmas, C.;
- Vadiaka, M.;
- Kanelopoulos, P.;
- Boulamatsis, D.
Publication type:
journal article

Found: 7

Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.

A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.

Irinotecan (CPT-11) in Patients with Advanced Colon Carcinoma Relapsing after 5-Fluorouracil-Leucovorin Combination.

Ondansentron and Dexamethasone Treatment with Different Dosing Schedules (24 versus 32 mg) in Patients with Non-Small-Cell Lung Cancer under Cisplatin-Based Chemotherapy:A Randomized Stud y.

Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study.

Efficacy of tropisetron in patients with advanced non-small-cell lung cancer receiving adjuvant chemotherapy with carboplatin and taxanes.

Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes.